DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Prochieve (Progesterone Vaginal) - Published Studies

 
 



Prochieve Related Published Studies

Well-designed clinical trials related to Prochieve (Progesterone Vaginal)

[Impacts on the duration of vaginal bleeding and the levels of serum estradiol (E2) and progesterone (P) for patients of midtrimester induction of labor treated with moxibustion at Guanyuan (CV 4) and Shenque (CV 8)]. [2011.09]

Vaginal micronized progesterone and risk of preterm delivery in high-risk twin pregnancies: secondary analysis of a placebo-controlled randomized trial and meta-analysis. [2011.09]

Prevention of preterm delivery in twin gestations (PREDICT): a multicenter, randomized, placebo-controlled trial on the effect of vaginal micronized progesterone. [2011.09]

Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. [2011.07]

Comparison of oral dydrogestrone with progesterone gel and micronized progesterone for luteal support in 1,373 women undergoing in vitro fertilization: a randomized clinical study. [2011.05]

Does cessation of progesterone supplementation during early pregnancy in patients treated with recFSH/GnRH antagonist affect ongoing pregnancy rates? A randomized controlled trial. [2011.05]

Progesterone effects on preterm birth in high-risk pregnancies: a randomized placebo-controlled trial. [2011.03]

Luteal phase progesterone increases live birth rate after frozen embryo transfer. [2011.02]

Patterns of luteal phase bleeding in in vitro fertilization cycles supplemented with Crinone vaginal gel and with intramuscular progesterone--impact of luteal estrogen: prospective, randomized study and post hoc analysis. [2011.02]

Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. [2011]

Crinone vaginal gel is equally effective and better tolerated than intramuscular progesterone for luteal phase support in in vitro fertilization-embryo transfer cycles: a prospective randomized study. [2010.12]

Endometrial effect of progesterone delivered by vaginal rings in estrogen-treated postmenopausal women. [2010.10]

Transdermal estradiol and oral or vaginal natural progesterone: bleeding patterns. [2010.10]

Single and multidose pharmacokinetic study of a vaginal micronized progesterone insert (Endometrin) compared with vaginal gel in healthy reproductive-aged female subjects. [2010.09]

Luteal phase progesterone increases live birth rate after frozen embryo transfer. [2010.06.24]

Study of progesterone for the prevention of preterm birth in twins (STOPPIT): findings from a trial-based cost-effectiveness analysis. [2010.04]

17-alpha-hydroxyprogesterone caproate for the prevention of preterm birth in women with prior preterm birth and a short cervical length. [2010.04]

Progesterone effects on preterm birth in high-risk pregnancies: a randomized placebo-controlled trial. [2010.01.22]

Efficacy of micronised vaginal progesterone versus oral dydrogestrone in the treatment of irregular dysfunctional uterine bleeding: a pilot randomised controlled trial. [2009.12]

Effect of progesterone on cervical shortening in women at risk for preterm birth: secondary analysis from a multinational, randomized, double-blind, placebo-controlled trial. [2009.12]

Pilot study evaluating a progesterone vaginal ring for luteal-phase replacement in donor oocyte recipients. [2009.11]

Effects of nonoral estradiol-micronized progesterone or low-dose oral estradiol-drospirenone therapy on metabolic variables and markers of endothelial function in early postmenopause. [2009.08]

[Effects and safety of gonadotrophin-releasing hormone agonist combined with estradiol patch and oral medroxyprogesterone acetate on endometriosis] [2009.07]

Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT): a randomised, double-blind, placebo-controlled study and meta-analysis. [2009.06.13]

Fixed-time AI pregnancy rate following insemination with frozen-thawed or fresh-extended semen in progesterone supplemented CO-Synch protocol in beef cows. [2009.04.15]

Progesterone after previous preterm birth for prevention of neonatal respiratory distress syndrome (PROGRESS): a randomised controlled trial. [2009.02.24]

Implanon versus medroxyprogesterone acetate: effects on pain scores in patients with symptomatic endometriosis--a pilot study. [2009.01]

Effects of early luteal-phase vaginal progesterone supplementation on the outcome of in vitro fertilization and embryo transfer. [2008.12]

Pilot study evaluating a progesterone vaginal ring for luteal-phase replacement in donor oocyte recipients. [2008.11.04]

Progesterone supplementation during cryopreserved embryo transfer cycles: efficacy and convenience of two vaginal formulations. [2008.09]

Comparison of Crinone 8% intravaginal gel and intramuscular progesterone supplementation for in vitro fertilization/embryo transfer in women under age 40: interim analysis of a prospective randomized trial. [2008.02]

Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial. [2007.10]

Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial. [2007.10]

Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial. [2007.10]

Progesterone and the risk of preterm birth among women with a short cervix. [2007.08.02]

Uteroplacental circulation in early pregnancy complicated by threatened abortion supplemented with vaginal micronized progesterone or oral dydrogesterone. [2007.03]

Comparison between two forms of vaginally administered progesterone for luteal phase support in assisted reproduction cycles. [2007.02]

Comparative study of the efficacy and tolerability of two vaginal progesterone formulations, Crinone 8% gel and Utrogestan capsules, used for luteal support. [2007.01]

Effects of tibolone and continuous combined conjugated equine estrogen/medroxyprogesterone acetate on the endometrium and vaginal bleeding: results of the OPAL study. [2006.11]

Transdermal progesterone cream as an alternative progestin in hormone therapy. [2005.11]

Relief of vasomotor symptoms and vaginal atrophy with three doses of conjugated estrogens and medroxyprogesterone acetate in postmenopausal Asian women from 11 countries: The Pan-Asia menopause (PAM) study. [2005.09.16]

Efficacy and tolerability of vaginal progesterone capsules (Utrogest 200) compared with progesterone gel (Crinone 8%) for luteal phase support during assisted reproduction. [2005.06]

Progesterone supplementation for preventing preterm birth: a systematic review and meta-analysis. [2005.06]

Vaginal ring delivering estradiol and progesterone: a possible alternative to relieve climacteric symptoms. [2005.05]

Effect on sexual life--a comparison between tibolone and continuous combined conjugated equine estrogens and medroxyprogesterone acetate. [2005.04]

Effect of antiprogesterone mifepristone followed by misoprostol on circulating leptin in early pregnancy. [2005.02]

Relationship between allopregnanolone and negative mood in postmenopausal women taking sequential hormone replacement therapy with vaginal progesterone. [2005.02]

Estradiol and the addition of progesterone increase the sensitivity to a neurosteroid in postmenopausal women. [2005.01]

Effects of vaginal progesterone on pain and uterine contractility in patients with threatened abortion before twelve weeks of pregnancy. [2004.12]

Progesterone supplementation during the early fetal period reduces pregnancy loss in high-yielding dairy cattle. [2004.11]

[A study of two different routes of administration of micronized progesterone in assisted reproduction] [2004.08]

17 alpha-hydroxyprogesterone caproate versus intravaginal progesterone in IVF-embryo transfer cycles: a prospective randomized study. [2004.07]

High local endometrial effect of vaginal progesterone gel. [2004.05]

Efficacy of oral micronized progesterone when applied via vaginal route. [2004.05]

Body mass index does not influence response to treatment, nor does body weight change with lower doses of conjugated estrogens and medroxyprogesterone acetate in early postmenopausal women. [2004.05]

Comparison of pregnancy outcomes of progesterone or progesterone + estradiol for luteal phase support in ICSI-ET cycles. [2004]

Effects of vaginal progesterone administration starting on the day of oocyte retrieval on pregnancy rates. [2003.12]

A randomised comparison of side effects and patient inconvenience of two vaginal progesterone formulations used for luteal support in in vitro fertilisation cycles. [2003.11.10]

Progesterone effects during sequential hormone replacement therapy. [2003.05]

The early response of the postmenopausal endometrium to tamoxifen: expression of estrogen receptors, progesterone receptors, and Ki-67 antigen. [2003.03]

Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. [2003.02]

Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy. [2003.01]

[Prevention of bone loss by estradiol valerate combined with medroxyprogesterone acetate among postmenopausal women with osteopenia] [2002.12.10]

Vaginal micronized progesterone in continuous hormone replacement therapy. A prospective randomized study. [2002.12]

The effects of short-term medroxyprogesterone acetate and micronized progesterone on glucose metabolism and lipid profiles in patients with polycystic ovary syndrome: a prospective randomized study. [2002.10]

Comparison of physical and emotional side effects of progesterone or medroxyprogesterone in early postmenopausal women. [2002.07]

Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women. [2002.05.22]

[Comparative study on two different dosages of conjugated equine estrogen continuously combined with medroxyprogesterone in prevention of postmenopausal osteoporosis] [2002.05]

Simplified artificial endometrial preparation, using oral estradiol and novel vaginal progesterone tablets: a prospective randomized study. [2002.04]

Growth of the uterus and mammary glands and vaginal cytologic features in extremely premature infants with postnatal replacement of estradiol and progesterone. [2002.02]

Progesterone supplementation during early gestations after IVF or ICSI has no effect on the delivery rates: a randomized controlled trial. [2002.02]

Sequential hormonal supplementation with vaginal estradiol and progesterone gel corrects the effect of clomiphene on the endometrium in oligo-ovulatory women. [2002.02]

Comparison of the efficacy and safety of two formulations of micronized progesterone (Ellios and Utrogestan) used as luteal phase support after in vitro fertilization. [2002.02]

[Pharmacokinetic comparison of progesterone capsules with a progesterone gel after vaginal administration] [2002]

Natural vaginal progesterone is associated with minimal psychological side effects: a preliminary study. [2001.12]

Delaying the initiation of progesterone supplementation results in decreased pregnancy rates after in vitro fertilization: a randomized, prospective study. [2001.12]

Uterorelaxing effects of vaginal progesterone: comparison of two methodologies for assessing uterine contraction frequency on ultrasound scans. [2001.10]

Estrogen and progesterone effects on transcapillary fluid dynamics. [2001.10]

[Luteal phase support in assisted reproductive cycles using either vaginal (Crinone 8) or intramuscular (Prontogest) progesterone: results of a prospective randomized study] [2001.08]

Effects of vaginal progesterone administration on uterine contractility at the time of embryo transfer. [2001.06]

Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on endometrial bleeding. [2001.06]

Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate. [2001.06]

Prospective, randomized study to evaluate the success rates using hCG, vaginal progesterone or a combination of both for luteal phase support. [2001.06]

Delayed first injection of the once-a-month injectable contraceptive containing 25 mg of medroxyprogesterone acetate and 5 mg of E(2)-cypionate: effects on ovarian function. [2001.04]

Prospective randomized trial to evaluate the efficacy of a vaginal ring releasing progesterone for IVF and oocyte donation. [2000.10]

The comparison of effects of tibolone and conjugated estrogen-medroxyprogesterone acetate therapy on sexual performance in postmenopausal women. [2000.07.31]

Vaginal delivery of progesterone in donor oocyte therapy. [2000.06]

Direct transport of progesterone from vagina to uterus. [2000.03]

A double-blind, randomized, comparative study evaluating clinical effects of two sequential estradiol-progestogen combinations containing either desogestrel or medroxyprogesterone acetate in climacteric women. [2000.02.15]

A prospective randomized study comparing intramuscular with intravaginal natural progesterone in programmed thaw cycles. [1999.10]

Luteal support with micronized progesterone following in-vitro fertilization using a down-regulation protocol with gonadotrophin-releasing hormone agonist: a comparative study between vaginal and oral administration. [1999.08]

Effects of acute administration of natural progesterone on peripheral vascular responsiveness in healthy postmenopausal women. [1999.07.15]

Evaluation of conjugated estrogen plus medroxyprogesterone acetate versus tibolone in early postmenopausal Chinese women. [1999.05]

A new clinical option for hormone replacement therapy in women with secondary amenorrhea: effects of cyclic administration of progesterone from the sustained-release vaginal gel Crinone (4% and 8%) on endometrial morphologic features and withdrawal bleeding. [1999.01]

Intramuscular versus vaginal administration of progesterone for luteal phase support after in vitro fertilization and embryo transfer. A comparative randomized study. [1999]

Endometrial morphology and ultrasound vascular findings. A randomized trial after intramuscular and vaginal progesterone supplementation in IVF. [1999]

Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women. [1998.09.22]

Menopausal symptom control and side-effects on continuous estrone sulfate and three doses of medroxyprogesterone acetate. Ogen/Provera Study Group. [1998.09]

Effectiveness of Cyclofem in the treatment of depot medroxyprogesterone acetate induced amenorrhea. [1998.01]

Experience with a novel vaginal progesterone preparation in a donor oocyte program. [1998.01]

Peripheral progesterone (P) levels and endometrial response to various dosages of vaginally administered P in estrogen-primed women. [1997.11]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017